|
|
Program
|
Thursday September 1st 2005 |
|
|
|
|
|
|
|
|
|
SYMPOSIUM 1: Uremic Toxins |
|
|
Chairman: R. Ward |
|
|
|
9:00 |
- |
9:10 |
|
Opening ISBP 2005 |
|
|
9:10 |
- |
9:35 |
|
R.C. Vanholder |
Gent |
Uremic toxins, where are we today? |
|
9:35 |
- |
10:00 |
|
Z. Massy |
Paris |
Uremic toxins and cardiovascular risc. |
|
10:00 |
- |
10:25 |
|
M.J. Lysaght |
Providence |
Treating uremia with microencapsulated enzymes. |
|
|
|
|
|
|
|
|
|
10:30 |
- |
11:00 |
|
Coffee and Tea |
|
|
|
|
|
|
|
|
|
|
|
Oral presentations 1: |
|
|
|
Chairman:F. Locatelli and F. van der Sanden
|
|
|
11:00 |
- |
11:15 |
|
M.M.H. Hermans |
Maastricht |
26: Association of serum fetuin-A (AHSG) concentrations with arterial stiffness in patients on dialysis. |
|
11:15 |
- |
11:30 |
|
M. Boehme |
Berlin |
4: Pentraxin 3 (PTX3) is elevated in hemodialysis (HD)- but not peritoneal dialysis (PD) patients and is associated with cardiovascular disease. |
|
11:30 |
- |
11:45 |
|
J. Axelsson |
Stockholm |
23: Are insulin-like growth factor (IGF)-I and its’ binding proteins (IGFBP)- 1 and -3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease patients on peritoneal dialysis? |
|
11:45 |
- |
12:00 |
|
T. Tokumoto |
Tokyo |
9: Change of bone lesion in hemodialysis patients with renal osteopathy after renal transplantation. |
|
12:00 |
- |
12:30 |
|
M. Ketteler |
Aachen |
Keynote speaker: Vascular calification in ESRD. |
|
|
|
|
|
|
|
|
|
12:30 |
- |
14:00 |
|
Buffet Lunch |
|
|
|
13:00 |
- |
14:00 |
|
Guided poster session 1 + 2 |
|
|
|
|
ISBP Award session:
Chairmen: T. Akiba and L. Smeby |
|
|
|
14:00 |
- |
14:10 |
|
Presentation of the
ISBP Award 2005 |
|
|
14:10 |
- |
14:40 |
|
Award lecture: Eberhard Ritz |
Heidelberg |
Cardiac death in endstage renal failure -
pathomechanisms and strategies to overcome the problem. |
|
|
|
|
|
|
|
|
|
SYMPOSIUM 2: The Heart in ESRD |
|
|
Chairman: R. Zietse |
|
|
|
14:40 |
- |
15:05 |
|
M. Zile |
Charleston |
Diastolic cardiac function. |
|
15:05 |
- |
15:35 |
|
E.H. Ie |
Rotterdam |
Pressure-volume relations in ESRD. |
|
15:35 |
- |
16:00 |
|
E. Paganini |
Cleveland |
Ultrafiltration in heart failure. |
|
|
|
|
|
|
|
|
|
16:00 |
- |
16:15 |
|
Coffee and Tea |
|
|
|
|
|
|
|
|
|
|
|
Oral presentations 2: |
|
|
Chairman: B. Lindholm and A. Davenport |
|
|
16:15 |
- |
16:30 |
|
C. Chazot |
Tassin |
33: Gradient between predialysis plasma sodium and prescribed sodium dialysate: a cross-sectional study in a large cohort of hemodialysis patients. |
|
16:30 |
- |
16:45 |
|
J. M. Kong |
Hong Kong |
7: Efficacy of ascorbic acid for epo-resistant anemia of hemodialysis patients: a double blind placebo controlled study. |
|
16:45 |
- |
17:00 |
|
P. Zemanova |
Pilsen |
25: Is it appropriate to tune regional citrate anticoagulation during hemodialysis by ionized calcium levels? |
|
17:00 |
- |
17:30 |
|
M. Hammerman |
St Louis |
Keynote speaker: Organogenesis of the kidney - Growing New Organs in Situ. |
|
17:30 |
- |
18:00 |
|
ISBP General Assembly |
|
|
Friday September 2nd 2005 |
|
|
|
|
|
|
|
|
|
SYMPOSIUM 3: Peritoneal Dialysis
|
|
|
Chairman: T. Golper and P. ter Wee |
|
|
|
9:00 |
- |
9:20 |
|
R. Selgas |
Madrid |
Mesothelial transdifferentiation. |
|
9:20 |
- |
9:40 |
|
J. Bargman |
Toronto |
PD and Residual Renal Function. |
|
9:40 |
- |
10:00 |
|
B. Lindholm |
Stockholm |
PD and inflammation. |
|
10:00 |
- |
10:20 |
|
R.T. Krediet |
Amsterdam |
New fluids in PD. |
|
|
|
|
|
|
|
|
|
10:20 |
- |
10:50 |
|
Coffee and Tea |
|
|
|
|
|
|
|
|
|
|
|
SYMPOSIUM 4: Hemodialysis |
|
|
Chairman: I. Ledebo and P.J. Blankestijn |
|
|
10:50 |
- |
11:15 |
|
R Schindler |
Berlin |
Clinical aspects of water treatment. |
|
11:15 |
|
11:40 |
|
PJ Blankestijn |
Utrecht |
Volume-independent mechanisms of hypertension in hemodialysis patients. |
|
11:40 |
|
12:05 |
|
D Fliser |
Hannover |
Endothelial progenitor cells in End Stage Renal Failure. |
|
12:05 |
|
12:30 |
|
J Rotmans |
Amsterdam |
Sirolimus eluting stents in PTFE loops. |
|
|
|
|
|
|
|
|
|
12:30 |
- |
14:00 |
|
Buffet Lunch |
|
|
|
13:00 |
- |
14:00 |
|
Guided poster session 3 + 4 |
|
|
|
|
Oral presentations 3: |
|
|
|
Chairman: T. Akiba and K. Leunissen |
|
|
14:00 |
- |
14:05 |
|
Presentation of best poster awards 2005 |
|
|
14:05 |
- |
14:10 |
|
Presentation of best abstract award 2005
|
|
|
14:10 |
- |
14:25 |
|
Best abstract:
M. Grooteman |
Amsterdam |
32: Dialyser biocompatibility and flux characteristics do not influence dimethylarginine levels in chronic hemodialysis patients. |
|
14:25 |
- |
14:40 |
|
V. Gura |
Los Angeles |
15: Wearable CRRT device for continuous hemodialysis or ultrafiltration. |
|
14:40 |
|
14:55 |
|
R. Dietrich |
Hechingen |
13: Development of an anti-thrombotic and anti-biofilm surface for application in vascular access technology. |
|
14:55 |
|
15:10 |
|
C. Doelman |
Eindhoven |
11: Stenosis detection in failing hemodialysis access fistulas and grafts: comparison of Color Doppler Ultrasonography, Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography. |
|
|
|
|
|
|
|
|
|
15:10 |
- |
15:30 |
|
Coffee and Tea |
|
|
|
|
|
|
|
|
|
|
|
SYMPOSIUM 5: The future of Dialysis |
|
Chairman: S. di Giulio |
|
|
15:30 |
- |
16:00 |
|
O. Devuyst |
Brussels |
From genetics to genomic medicine: Perspectives for dialysis patients. |
|
16:00 |
- |
16:30 |
|
F. Locatelli |
Lecco |
Which issues should be addressed in Future trials in Dialysis. |
|
16:30 |
- |
16:45 |
|
Discussion |
|
|
|
16:45 |
- |
16:50 |
|
Concluding remarks and announcement of ISBP 2006 |
|
Poster session 1 Thursday September 1st 2005 Chairman: |
P1 [Abstract nr 1] Successful Use of Albumin Dialysis for Hypoxic Liver Failure After Cardiac Surgery. O.T. Corsmit, C.V. Elzo Kraemer, J.J. Maas, R.J.M. Klautz, P.C.M. van den Berg Leiden University Medical Center, Leiden, The Netherlands
P2 [Abstract nr 2] Adiponectin in Long-term Hemodialysis Patients. M. Kubo, K. Tago Tago Kidney and Urology Clinic, Japan
P3 [Abstract nr 3] Is Hypertension or Hypotension the True Problem in Patients on Extracorporeal Dialysis (RDT)? G. Calabrese, A. Mazzotta, G. Vagelli, M. Gonella Renal Unit, Ospedale S. Spirito, Casale Monferrato, Italy
P4 [Abstract nr 5] Risk Factors for Lower Limb Amputations (LLA) in Incident Haemodialysis Patients from Two European Countries. A. Ferreiraa, A. Di Benedettob, P. Poncec, S. Cesareb, J. Kirchgessnerd, D. Marcellid aHemodial, Clínica de Diálise, Vila Franca de Xira, Portugal, bFresenius Medical Care, Italy, cFresenius Medical Care Portugal, dClinical Management Europe, FreseniusMedical Care, Bad Homburg, Germany
P5 [Abstract nr 6] Inflammation and Cardiovascular Disease Markers in Haemodialysis Patients. P. Matiasa, I. Airesa, C. Jorgea, S. Marumb, H. Lagec, C. Gila, F. Gomesa, E. Arranhadoc, A. Ferreiraa aHemodial, Vila Franca de Xira, bIntensive Care Unit, cLaboratory of Immunology, Hospital Curry Cabral, Lisbon
P6 [Abstract nr 8] Study of Countermeasures to Prevent Di(2 etylehexyl) Phtalate Elution from Blood Tubing Y. Kan-noa, T. Shibamotoa, N. Itob, Y. Yoshimotoa, M. Fukasea, N. Teradaa, M. Kuwaharaa, S. Sasakia aDepartment of Blood Purification, Tokyo Med and Dent Univ (Japan), bNIKKISO Medical Co Ltd, Tokyo, Japan
P7 [Abstract nr 10] Acute Renal Failure in Patients with Severe Hyponatremia. E.J. Hoorna, J. Lindemansb, R. Zietsea aDepartment of Internal Medicine, bDepartment of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands
|
Poster session 2 Thursday September 1st 2005 Chairman: |
P8 [Abstract nr 12] Vascular Access Intervention Therapy Using Gadolinium for Patients with Iodine Allergy. M. Fukasawaa, H. Skamotob, M. Takedaa aDepartment of Urology, University of Yamanashi, bDepartment of Clinical Radiology, University of Yamanashi, Japan
P9 [Abstract nr 14] Use of The Organized Cuff Shaving in the Procedures of Substitution of Septic Permanent Tunneled Central Venous Catheters. B. Ricciardia, A. Saranitia, F. Gittoa, A. Saporitaa, A. Pontorieroa, A. Ragusaa, A. Scirèa, G. Bellinghierib aU.O.C. di Nefrologia e Dialisi Milazzo – Lipari, A.U.S.L. n 5 Messina, bChair of Nephrology, Messina University, Italy
P10 [Abstract nr 16] Does a Reduction of Adhesion Molecules by LDL-apheresis Have a Role in The Treatment of Sudden Hearing Loss? A. Ramunnia, N. Quarantab, M.T. Saliania, R.M. Fallacarab, R. Riac, G. Ranieri aSection of Nephrology, Department of Internal and Public Medicine, bOtolaryngology Clinic ‘G. Lugli’, Department of Opthalmology and Otorhinolaryngology, cSection of Internal Medicine, Department of Biomedical Sciences and Human Oncology, University of Bari, Italy
P11 [Abstract nr 17] Replacement Therapy of Liver Detoxifying Function by MARS in Acute on Chronic Failure. R. Marangoni Liver Unit, S. Giuseppe Hospital, Milan, Italy
P12 [Abstract nr 18] Association Active C Protein/Haemoperfusion on Adsorbent Cartridge with ‘B Polymyxin’, in a Patient Affected by Acute Kidney Failure and Sepsis. B. Ricciardia, A. Pontorieroa, D. Grassob, A. Saranitia, F. Gittoa, A. Saporitaa, A. Ragusaa, C. Morminab, M. Scibiliab,S. Bolignanob, M. Frigioneb, G. Bellinghieric aUnit of Nephrology and Dialysis Milazzo/Lipari, bUnit. of Anaesthesia and Reanimation, Milazzo Hospital A.U.S.L. n 5 Messina, cChair of Nephrology of Messina University, Italy
P13 [Abstract nr 19] Existence of Microbial Contaminations in Endotoxin Free Dialysate. I. Masakanea, H. Kanedaa, Y. Kurodaa, S. Moriyaa, Y. Tannnoa, H. Ohgiyab aYabuki Hospital, bIzumi Central Hospital,Yamagata, Japan
P14 [Abstract nr 20] On-line Hemodiafiltration is Effective to Keep Muscle Volume in CKD Patients. I. Masakanea, H. Sekib, R. Atsumib, Y. Shishidob aYabuki Hospital, bMidorino-sato Clinic, Yamagata, Japan
|
Poster session 3 Friday September 2nd 2005 Chairman: |
P15 [Abstract nr 21] Examination of 2 Cases That Enforces Endotoxin Hemoadsorption Treatment for Septic Shock. Y. Minagawa Kuji Hospital, Kuji, Japan
P16 [Abstract nr 22] Experiences with CVVH As a New Treatment Modality in Our Paediatric and Neonatal ICU. L. Koster-Kamphuis, A. van As University Children’s Hospital St Radboud Nijmegen, The Netherlands
P17 [Abstract nr 24] Hypotension in Peritoneal Dialysis-more than Hypovolemia. M. Avramovic Institute of Nephrology and Hemodialysis, Medical School of Nis, Serbia and Montenegro
P18 [Abstract nr 27] Optimum Sieving and Biocompatibility Profiles of The New High-Flux Dialysis Membrane Purema® H. D.H. Krietera, A. Barasinskia, A. Morgenrothb, H.-D. Lemkec, C. Wannera aDepartment of Medicine, Division of Nephrology, University of Würzburg, bDialysis Center Elsenfeld, cMembrana Research, Obernburg, Germany
P19 [Abstract nr 28] Disturbed Mineral Metabolism is Associated with Cardiovascular Morbidity in Dialysis Patients. M. Noordzija, J.C. Korevaara, E.W. Boeschotenb, F.W. Dekkerc, W.J. Bosd, R.T. Krediete aDept. of Clinical Epidemiology and Biostatistics, AMC, University of Amsterdam, bHans Mak Institute, Naarden, cDept. of Clinical Epidemiology, LUMC, University of Leiden, dDept. of Internal Medicine, St. Antonius Hospital, Nieuwegein, eDept. of Nephrology, AMC, University of Amsterdam, The Netherlands
P20 [Abstract nr 29] Investigation of Activated Blood Substances in the Measuring of Whole Blood Clotting Time During Hemodialysis. K. Abea, T. Hashimotoa, M. Nokia, T. Shibamotob, M. Hoshinoa aHemodialysis Unit, SEISHOUKAI Memorial Hospital (Japan), bDepartment of Blood Purification, Tokyo Med. and Dent. Univ., Tokyo, Japan
P21 [Abstract nr 30] The Association Between Body Mass Index and All-cause Mortality in Dutch Incident Hemodialysis Patients. R. de Mutserta, F. van der Sman-de Beera, J.S. Mourera, E.W. Boeschotenb, R.T. Kredietc, F.W. Dekkerc aLUMC, Leiden, bHans Mak Institute, Naarden, cAMC, Amsterdam, The Netherlands
|
Poster session 4 Friday September 2nd 2005 Chairman: |
P22 [Abstract nr 31] Effects of GI Medication to The Mineral Metabolism Control in Patients Undergoing Hemodialysis. N. Kimataa, T. Satob, K. Abec, M. Hoshinoc, T. Akibaa aDepartment of Blood Purification, Kidney Center, Tokyo Women’s Medical University, bUrayasu-ekimae Clinic, cSaishokai Memorial Hospital, Japan
P23 [Abstract nr 34] Intradialytic Hemodynamic Instability: Effects of Cool Temperature Dialysate, Citrate and Platelet Activity. M. Grittersa, P. Borgdorffb, M. Schoorlc, M.P.C. Grootemand, P.C.M. Bartelsc, G.J. Tangelderb, M.J. Nubéa aNephrology, Medical Center Alkmaar, bPhysiology, VU University, cBiochemistry, Medical Center Alkmaar, dNephrology, VU University Medical Center, Amsterdam, The Netherlands
P24 [Abstract nr 35] Experiences with Therapeutic Plasma Exchange (TPE) in Our Paediatric Dialysis Unit During Ten Years. L. Koster-Kamphuis, N. van de Kar University Children’s Hospital St Radboud Nijmegen, The Netherlands
P25 [Abstract nr 36] Low-Density Lipoprotein Apheresis Ameliorated the Digital Gangrene Caused by Repeated Puncture into Subcutaneously Fixed Superficial Brachial Artery in a Hemodialysis Patient. K. Tsuchida, Y. Takemoto, H. Kuroki, I. Go, M. Matsuyama, R. Yoshimura, K. Sugimura, T. Nakatani Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan
P26 [Abstract nr 37] Therapeutic Plasma Exchange (TPE) with Haemonetics PCS for the Treatment of Acute Hypertriglyceridemia. A. Griskevicius, J. Audzijoniene, A. Baublys Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
P27 [Abstract nr 38] Bidialysis On Line: A New Solution for Ipercatabolic or High Body Weight Hemodialysis Patients S. Giorgio, C. Stefano, C. Roberto, F. Antonia, N. Laura, C. Carmela Department of Nephrology, Tor Vergata University, Rome, Italy
P28 [Abstract nr 39] Kinetic Studies on Urea Extraction with Hemodialysis in Children and Adolescents by On-Line Monitoring of Dialysate Urea A.D. Marina, K.-E. Bonzel, T. Drossert, M. Kreuzer, R. Büscher, B. Kranz, P. F. Hoyer Clinic for Paediatric Nephrology, University Children’s Hospital Essen, Germany
|
|
|